Why Choose Safety-Coated Ecotrin®?
Clinically Proven
Ecotrin is clinically proven to be safer than plain or buffered aspirin.
In 1993 Dr. Donald Petroski recognized that chronic aspirin therapy was becoming an increasingly common medical practice. He conducted a study to evaluate the effect of three types of aspirin on the stomach.
Conclusions from the study:
Long-term/chronic use of plain or buffered aspirin can cause significant damage to the gastrointestinal mucosa (the membrane lining of the stomach).
Patients requiring long-term/chronic aspirin therapy may be protected from stomach damage by using a safety-coated aspirin such as Ecotrin. In fact, safety-coated Ecotrin has been shown to be effective and safe in over 40 years of clinical use.
See the Statistics
In the study that compared plain and buffered aspirin with Ecotrin and a placebo, Ecotrin and the placebo were not statistically different from one another in the gastric damage produced. Significant damage to the gastric mucosa was seen with plain and buffered aspirin. See the chart above.
Bayer is a registered trademark of Bayer Corporation.
Bufferin is a registered trademark of Bristol Meyers Squibb.
|